AmerisourceBergen’s distribution center in Sacramento is in danger of losing its license for allegedly selling excessive amounts of opioids to local pharmacies, writes Felicia Alvarez for the Sacramento Business Journal.
The site is one of the Chesterbrook-based company’s three distribution centers in the Golden State.
At the end of May, the California State Board of Pharmacy filed accusations to all three centers for allegations over excessive drug orders recorded in the company’s system. The accusation calls for a hearing to potentially revoke or suspend the company’s wholesale distribution permits in California. A time for the hearing has not yet been set.
The Sacramento facility has been accused of furnishing “excessive amounts” of controlled substances to four pharmacies in Northern California. According to the complaint, AmerisourceBergen is accused of delivering a high volume of pain drugs without ensuring they were being dispensed for “legitimate medical purposes.”
AmerisourceBergen responded to the accusation by stating it only ships to pharmacies that have valid pharmacy boards and DEA licenses.
“AmerisourceBergen is committed to combating opioid abuse and has always complied with the Controlled Substances Act,” said spokesman Gabe Weissman.
Read more about AmerisourceBergen in the Sacramento Business Journal here.